Metabolomics in Advanced Liver Disease

被引:1
作者
Noora Kano
Elizabeth J. Want
Mark J. W. McPhail
机构
[1] Imperial College London,Section of Biomolecular Medicine, Department of Metabolism, Digestion and Reproduction
[2] Kings College London,Institute of Liver Studies, Department of Inflammation Biology, School of Immunity and Microbial Sciences
关键词
Cirrhosis; liver failure; metabolomics; biomarkers; hepatocellular carcinoma; diagnosis;
D O I
10.1007/s11938-021-00347-w
中图分类号
学科分类号
摘要
引用
收藏
页码:380 / 397
页数:17
相关论文
共 279 条
[21]  
Trebicka J(2010)Targeted metabolomics for biomarker discovery Angewandte Chemie International Edition. 49 5426-3100
[22]  
Fernandez J(2015)The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research Methods Mol Biol. 1277 161-442
[23]  
Papp M(2020)Integration of GC–MS and LC–MS for untargeted metabolomics profiling Journal of Pharmaceutical and Biomedical Analysis. 190 113509-97
[24]  
Caraceni P(2019)NMR spectroscopy for metabolomics research Metabolites. 9 123-299
[25]  
Laleman W(2017)UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research Drug Discov Today. 22 463-2227
[26]  
Gambino C(2018)GC/MS in recent years has defined the normal and clinically disordered steroidome: will it soon be surpassed by LC/tandem MS in this role? J Endocr Soc. 2 974-1365
[27]  
Hernaez R(2017)Hyphenated MS-based targeted approaches in metabolomics Analyst. 142 3079-341
[28]  
Sola E(2016)Data analysis strategies for targeted and untargeted LC-MS metabolomic studies: overview and workflow TrAC Trends in Analytical Chemistry. 82 425-47
[29]  
Moreau R(2012)NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review Anal Chim Acta. 750 82-290
[30]  
Gines P(2013)Translational biomarker discovery in clinical metabolomics: an introductory tutorial Metabolomics. 9 280-947